posted on 2011-09-15, 01:26authored byNnenna A. Finn, Harry W. Findley, Melissa L. Kemp
The toxicity-generating module is NADPH-limited at the high Dox condition, allowing DHEA administration to decrease NADPH-dependent semiquinone doxorubicin formation. The signal-generating module is NADPH-limited at the low Dox condition, allowing DHEA administration to decrease NADPH-dependent superoxide formation.